Chester County News and Community Website
WASHINGTON, D.C. — The Centers for Disease Control and Prevention (CDC) has issued a fresh set of recommendations for the upcoming 2024-2025 period, calling for updated COVID-19 and seasonal flu …
New Season, New Protection: CDC Urges Updated COVID-19 and Flu Vaccinations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has greenlit the marketing of a ground-breaking Hepatitis C virus (HCV) test, developed by Cepheid, marking a significant step in …
FDA Approves Revolutionary Hepatitis C Test: A Game Changer in Disease Diagnosis and Management Read More
WASHINGTON, D.C. — In preparation for the upcoming respiratory virus season, the Centers for Disease Control and Prevention (CDC) recently updated its guidance on the use of Respiratory Syncytial Virus …
CDC Recommends RSV Vaccine for Older Adults Ahead of Respiratory Virus Season Read More
EDEN PRAIRIE, MN, and REHOVOT, Israel, and EXTON, PA — Stratasys Ltd. (NASDAQ: SSYS) and Ricoh USA, Inc. have announced the enrollment of the first patient in a pioneering clinical …
Groundbreaking Study to Evaluate 3D Printed Models in Orthopedic Oncology Surgery Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has given its full approval to Sirturo (bedaquiline), a drug used in the treatment of pulmonary tuberculosis (TB) that is resistant …
FDA Grants Full Approval to Sirturo for Treatment of Multi-Drug Resistant Tuberculosis Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval for a new treatment combination for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC). …
FDA Grants Accelerated Approval to New Colorectal Cancer Treatment Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has unveiled a new initiative aimed at reimagining homes as central hubs for health care. Announced Thursday, the Home as a …
FDA Launches Initiative to Transform Homes into Health Care Hubs Read More
WASHINGTON, D.C. — This week, in a significant step for the medical world and hope for patients, the U.S. Food and Drug Administration expanded the approval of Elevidys, a gene …
FDA Broadens Approval of Elevidys Gene Therapy for Duchenne Muscular Dystrophy Patients Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) this week announced the progression of its OCU410ST GARDian clinical trial after the Data and Safety Monitoring Board (DSMB) approved moving forward with …
Ocugen Advances Stargardt Disease Therapy with Positive Clinical Trial Progress Read More
WASHINGTON, D.C. — On Thursday, U.S. Senators Bob Casey (D-PA) and Markwayne Mullin (R-OK) introduced the Creating Hope Reauthorization Act, a bipartisan effort aimed at encouraging pharmaceutical companies to develop …
Senate Leaders Push for Reauthorization of Program to Combat Rare Pediatric Diseases Read More